Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 10/20 | 0.40 |
| ▸ | TET3 | O43151 | 9/20 | 0.40 |
| ▸ | FBXL19 | Q6PCT2 | 9/20 | 0.40 |
| ▸ | KDM2B | Q8NHM5 | 9/20 | 0.40 |
| ▸ | CXXC4 | Q9H2H0 | 9/20 | 0.40 |
| ▸ | KDM2A | Q9Y2K7 | 9/20 | 0.40 |
| ▸ | CXXC5 | Q7LFL8 | 8/20 | 0.40 |
| ▸ | TET1 | Q8NFU7 | 7/20 | 0.40 |
| ▸ | JAK3 | P52333 | 4/20 | 0.34 |
| ▸ | BTK | Q06187 | 3/20 | 0.32 |
| ▸ | VNN1 | O95497 | 1/20 | 0.32 |
| ▸ | TXK | P42681 | 1/20 | 0.31 |
| ▸ | ITK | Q08881 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24497417 | 1.00 | KMT2A (0.40) | KMT2ATET3FBXL19KDM2BCXXC4 | |
| SCHEMBL24595770 | 0.90 | JAK3 (0.40) | KMT2ATET3FBXL19KDM2BCXXC4 | |
| SCHEMBL25207893 | 0.89 | KMT2A (0.45) | KMT2ATET3FBXL19KDM2BCXXC4 | |
| SCHEMBL29333077 | 0.85 | KMT2A (0.35) | KMT2ATET3FBXL19KDM2BCXXC4 | |
| SCHEMBL23137147 | 0.80 | TET3 (0.32) | KMT2ATET3FBXL19KDM2BCXXC4 | |
| SCHEMBL24244455 | 0.80 | KMT2A (0.44) | KMT2ATET3FBXL19KDM2BCXXC4 | |
| SCHEMBL25976873 | 0.79 | KMT2A (0.44) | KMT2ATET3FBXL19KDM2BCXXC4 | |
| SCHEMBL13819676 | 0.78 | SMN1; SMN2 (0.39) | KMT2AVNN1ALDH1A1 | |
| SCHEMBL13819904 | 0.78 | SMN1; SMN2 (0.39) | KMT2AVNN1ALDH1A1 | |
| SCHEMBL22145440 | 0.77 | KMT2A (0.46) | KMT2ATET3FBXL19KDM2BCXXC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020081572-A1 | TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-04-23 | — | — | WO | disclosed |